Stock 000739 APELOA PHARMACEUTICAL CO.,LTD
Add to a list
To use this feature you must be a member
Log inSign up

Company Apeloa Pharmaceutical Co.,Ltd

Equities

000739

CNE000000Q45

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 23:00:00 29/04/2024 BST 		5-day change 1st Jan Change
14.11 CNY +1.36% Intraday chart for Apeloa Pharmaceutical Co.,Ltd +3.75% -8.32%
04-17 Apeloa Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
03-27 Apeloa Pharmaceutical Co.,Ltd announces an Equity Buyback for CNY 300 million worth of its shares. CI

Business Summary

Apeloa Pharmaceutical Co Ltd is a China-based company principally engaged in the research and development, production and sales of Active Pharmaceutical Ingredient (API) intermediates, contract development and manufacturing organization (CDMO), preparations and others, as well as import and export trade. The Company operates three businesses. The API intermediates business mainly includes cephalosporin series, penicillin series, psychiatric series, cardiovascular and cerebrovascular series and veterinary API intermediates series. The CDMO business mainly includes research and development services, commercial human drug projects, commercial veterinary drug projects and other commercial products. The preparation business mainly includes anti-infective, cardiovascular and cerebrovascular, psychiatric and anti-tumor preparation products. The Company mainly operates its businesses in domestic and overseas markets.

Number of employees: 7,208

Sales per Business

CNY in Million2022Weight2023Weight Delta
API Intermediates
69.6 %
7,737 73.4 % 7,987 69.6 % +3.23%
Innovative Drug R&D and Production Services
17.5 %
1,577 15.0 % 2,005 17.5 % +27.10%
Preparation
10.9 %
1,080 10.2 % 1,249 10.9 % +15.69%
Others
1.7 %
112 1.1 % 199 1.7 % +78.23%
Other Business
0.3 %
39 0.4 % 34 0.3 % -13.25%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
57.1 %
5,997 56.9 % 6,555 57.1 % +9.30%
Foreign
42.9 %
4,548 43.1 % 4,919 42.9 % +8.17%

Managers

Managers TitleAgeSince
Xin Liang Xu CEO
 Chief Executive Officer 55 01/01/20
Jin Hui Zhang DFI
 Director of Finance/CFO 49 06/03/19
Fang Meng Zhu CHM
 Chairman 52 -
Yun Na Lou IRC
 Investor Relations Contact - -
Chun He PRN
 Corporate Officer/Principal 50 01/01/20
Yu Wang Zhou SEC
 Corporate Secretary 58 09/04/18

Members of the board

Members of the board TitleAgeSince
Wen Cai Xu BRD
 Director/Board Member 58 14/04/05
Ling Chen BRD
 Director/Board Member 58 07/04/20
Xiang Quan Ge BRD
 Director/Board Member 50 17/04/23
Tian Gao Hu BRD
 Director/Board Member 59 15/05/08
Juan Ping Qian BRD
 Director/Board Member 60 09/04/21
Guo Ping Li CHM
 Chairman 51 20/12/17
Fang Meng Zhu CHM
 Chairman 52 -
Xing Wu BRD
 Director/Board Member 52 26/02/13
Wei Guang Pan BRD
 Director/Board Member 54 30/03/22
Wen Bin Nie BRD
 Director/Board Member 58 30/11/17

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,178,523,492 554,213,990 ( 47.03 %) 9,199,916 ( 0.7806 %) 47.03 %

Shareholders

NameEquities%Valuation
Hengdian Group Holdings Co., Ltd.
50.23 %
591,928,655 50.23 % 1 028 M ¥
Chengdu Hengrun Hi-Tech Co., Ltd.
5.065 %
59,683,845 5.065 % 104 M ¥
Aegon-Industrial Fund Management Co., Ltd.
4.849 %
57,143,834 4.849 % 99 M ¥
Rongtong Fund Management Co., Ltd.
2.355 %
27,745,479 2.355 % 48 M ¥
APELOA PHARMACEUTICAL CO.,LTD
1.914 %
22,559,016 1.914 % 39 M ¥
Essence Fund Co., Ltd.
1.031 %
12,148,412 1.031 % 21 M ¥
GF Fund Management Co., Ltd.
0.8881 %
10,465,657 0.8881 % 18 M ¥
Dongyang Hengdian Yushan Sports & Leisure Co. Ltd.
0.7843 %
9,241,603 0.7843 % 16 M ¥
Guotai Asset Management Co., Ltd.
0.7200 %
8,484,500 0.7200 % 15 M ¥
Golden Trust Sinopac Fund Management Co., Ltd.
0.6390 %
7,529,507 0.6390 % 13 M ¥

Holdings

NameEquities%Valuation
APELOA PHARMACEUTICAL CO.,LTD
1.91%
 22,559,016 1.91% 39,172,378 $

Company contact information

Apeloa Pharmaceutical Co., Ltd.

No. 399, Jiangnan Road Hengdian Town

322118, Jinhua

+

http://www.apeloa.com
address Apeloa Pharmaceutical Co.,Ltd(000739)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Apeloa Pharmaceutical Co.,Ltd

Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
14.11 CNY
Average target price
17.75 CNY
Spread / Average Target
+25.80%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
APELOA PHARMACEUTICAL CO.,LTD Stock Apeloa Pharmaceutical Co.,Ltd
-8.32% 2.28B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+26.08% 681B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+21.85% 556B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.77% 361B
MERCK & CO., INC. Stock Merck & Co., Inc.
+16.97% 325B
ABBVIE INC. Stock AbbVie Inc.
+5.69% 285B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.68% 235B
NOVARTIS AG Stock Novartis AG
+3.65% 199B
ROCHE HOLDING AG Stock Roche Holding AG
-11.12% 189B
PFIZER, INC. Stock Pfizer, Inc.
-3.40% 157B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 000739 Stock
  4. Company Apeloa Pharmaceutical Co.,Ltd